Archives: Press Releases

MENLO PARK, Calif., May 9, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2024. First quarter results: Revenue of $38.8 million compared with $38.9…

Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 – $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif., April 16, 2024…

HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Reproductive Health, Drug Response, Cancer Research…

HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif., March 12, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly…

MENLO PARK, Calif., Feb. 26, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming…

MENLO PARK, Calif., Feb. 15, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2023. Fourth quarter results Revenue of $58.4 million, a…

New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif., Feb. 5, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate…

MENLO PARK, Calif., Jan. 25, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2023 financial results on…

Existing HT CBB Kit Enables High-Throughput Extraction of HMW DNA Tailored for HiFi With an Updated Workflow for Animal Blood and Bacteria MENLO PARK, Calif., Jan. 15, 2024 /PRNewswire/ —…

Ships a record number of PacBio sequencers in 2023, including 173 Revio™ systems, and announces record fourth quarter preliminary consumable revenue of $18.9 million as demand for long-read sequencing grows…

MENLO PARK, Calif., Dec. 27, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 42nd Annual…

MENLO PARK, Calif., Dec. 11, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that David Botstein, Ph.D., a member of PacBio’s…

MENLO PARK, Calif., Nov. 9, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming…

Consortium Aims to Share Best Practices and Increase our Understanding of Genetic Disease MENLO PARK, Calif., Nov. 2, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate…

Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif., Nov. 1, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality,…